Abrinica, Clyde .

HRN: 27-22-75  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/28/2025
09/03/2025
IV
40mg
Q8h
PCAP D
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines